| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977914 | Brachytherapy | 2010 | 5 Pages |
Abstract
Adjuvant therapy for UPSC and CCC with intraperitoneal 32P and vaginal brachytherapy after adequate surgical staging and maximal cytoreduction is well tolerated and appears to be effective. Further study is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Achilles J. Fakiris, Mark Henderson, Simon S. Lo, Katherine Y. Look, Higinia R. Cardenes,